PTC Therapeutics prices IPO at $15, within the range


PTC Therapeutics, a biotech targeting rare forms of muscular dystrophy and cystic fibrosis, raised $126 million by offering 8.4 million shares at $15.00, within the range of $13.00 to $16.00. PTC Therapeutics plans to list on the NASDAQ under the symbol PTCT. PTC Therapeutics initially filed confidentially on 3/18/2013. J.P. Morgan and Credit Suisse acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: News Headlines , IPOs

Referenced Stocks:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by